Tag: Nilesh Gupta
Lupin founder Desh Bandhu Gupta’s biography launched in Mumbai
The book titled "Made in India – The story of Desh Bandhu Gupta, Lupin and Indian Pharma" has been authored by Manish Sabharwal and Sundeep Khanna
Lupin receives Health Canada approval for biosimilar Pegfilgrastim
This product will be marketed under the brand name Armlupeg® and manufactured at Lupin’s Biotech facility at Pune, India
Lupin gets EIR from US FDA for its Ankleshwar manufacturing facility
The inspection of the facility was conducted from August 16-19, 2022
Lupin appoints Diana Amador-Toro as Senior Vice President, Global Compliance
Diana is a senior leader with more than 38 years of field experience in U.S. FDA’s Office of Regulatory Affairs (ORA)
Pharma industry reiterates its commitment to US$ 130 billon by 2030
Innovation, R&D, partnership & policy support to be key growth drivers as echoed at Global Innovation Summit-2021 organized by Indian Pharmaceutical Alliance
Lupin acquires Southern Cross Pharma in Australia
As a part of the transaction, Generic Health will gain access to over 60 registered products having sales of over AUD 30 Mn (approximately USD 22 Mn)...................
Lupin gets US-FDA nod for its Pegfilgrastim biosimilar application
The Biologics License Application (BLA) submission is supported by similarity data from analytical, pharmacokinetic, pharmacodynamic and immunogenicity studies........................